About
Technology
Issues
FAQ
Links
Official Page
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.